Synthesis and Evaluation of Novel Pyrroles and Pyrrolopyrimidines as Anti-Hyperglycemic Agents
Figure 2
(a) Pyrroles as antihyperglycemic agents [19, 20], (b) Amaryl, standard antihyperglycemic drug [21, 22], and approved DPP-IV inhibitors [23–25] as type 2 diabetes medications containing a pyrrole moiety. (c) Thieno and Pyrrolo-pyrimidines as DPP-IV inhibitors.
